Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

Acute graft-versus-host disease (aGvHD) is the major barrier to the broader use of allogenetic hematopoietic stem cells. However, currently these are no highly specific and efficient drugs. Monotherapy is not sufficient and more efficient and safe therapeutic regimen are urgent need. Studies demonst...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Jia, Huijie, Zhao, Tiesuo, Ji, Yinghua, Jia, Xiaolong, Ren, Wenjing, Li, Chen, Li, Minming, Xiao, Yali, Wang, Hui, Xu, Kailin
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5261008/
https://ncbi.nlm.nih.gov/pubmed/27906171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2016.399
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados